13 patents
Utility
Nasal formulations of metoclopramide
14 Nov 23
Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided.
Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
Filed: 2 Jul 21
Utility
Nasal formulations of metoclopramide
18 Apr 23
Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided.
Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
Filed: 20 Nov 20
Utility
Treatment of Moderate and Severe Gastroparesis
30 Mar 23
Metoclopramide is administered for the treatment of moderate to severe gastroparesis, in some embodiments, severe gastroparesis.
Marilyn R. CARLSON, Matthew J. D'ONOFRIO, David A. GONYER, Wayne ALVES
Filed: 18 Oct 22
Utility
Treatment of moderate and severe gastroparesis
6 Dec 22
Metoclopramide is administered for the treatment of moderate to severe gastroparesis, in some embodiments, severe gastroparesis.
Marilyn R. Carlson, Matthew J. D'Onofrio, David A. Gonyer, Wayne Alves
Filed: 13 Dec 17
Utility
Nasal Formulations of Metoclopramide
4 Nov 21
Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided.
Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
Filed: 2 Jul 21
Utility
Nasal Formulations of Metoclopramide
28 Oct 21
Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided.
Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
Filed: 2 Jul 21
Utility
Nasal Formulations of Metoclopramide
28 Oct 21
Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided.
Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
Filed: 2 Jul 21
Utility
Nasal formulations of metoclopramide
1 Jun 21
Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided.
Matthew J. D'Onofrio, David A. Gonyer, Shirish A. Shah, Stuart J. Madden
Filed: 6 Nov 18
Utility
Nasal Formulations of Metoclopramide
1 Apr 21
Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided.
Matthew J. D'ONOFRIO, David A. GONYER, Shirish A. SHAH, Stuart J. MADDEN
Filed: 20 Nov 20
Utility
CorrectedTreatment of Symptoms Associated with Female Gastroparesis
30 Dec 20
Nasal formulations of metoclopramide are administered for the treatment of symptoms associated with female gastroparesis.
Matthew J. D'ONOFRIO, David A. GONYER, Marilyn R. CARLSON
Filed: 21 Jun 18
Utility
Methods of Intranasal Metoclopramide Dosing
2 Sep 20
The present disclosure relates to methods of intranasal metoclopramide dosing.
Marilyn R. CARLSON, Wayne ALVES, Matthew J. D'ONOFRIO, David A. GONYER
Filed: 9 Sep 18
Utility
Treatment of Symptoms Associated with Female Gastroparesis
25 Dec 19
Nasal formulations of metoclopramide are administered for the treatment of symptoms associated with female gastroparesis.
Matthew J. D'ONOFRIO, David A. GONYER, Marilyn R. CARLSON
Filed: 21 Jun 18
Utility
Treatment of Moderate and Severe Gastroparesis
30 Oct 19
Metoclopramide is administered for the treatment of moderate to severe gastroparesis, in some embodiments, severe gastroparesis.
Marilyn R. CARLSON, Matthew J. D'ONOFRIO, David A. GONYER, Wayne ALVES
Filed: 12 Dec 17
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first